A Georgia woman is suing Kaiser Permanente after she says a pathology error led doctors to diagnose her with aggressive uterine cancer and perform a hysterectomy that she did not need.
Cassandra Barksdale, 43, sought medical care in early 2025 after experiencing heavy bleeding associated with uterine fibroids. According to her lawsuit, she underwent a biopsy on March 10, 2025, and was told several days later that the results showed high-grade, aggressive endometrial cancer. She underwent a full hysterectomy on May 15, 2025.
The lawsuit alleges that DNA analysis later indicated that the tissue sample showing cancer belonged to another patient. Barksdale was reportedly informed of the finding in September 2025. According to the lawsuit, subsequent examination of tissue removed during her surgery found no malignancy.
The lawsuit is seeking unspecified damages. Kaiser Permanente has acknowledged the seriousness of what happened but has not accepted the allegations as described in the lawsuit. The organization said, "Ms. Barksdale should not have experienced this," and said it had implemented measures intended to prevent a similar incident.
Because the case remains in litigation, the allegations should not be treated as a final determination of responsibility.
When a Specimen Error Can Change a Cancer Diagnosis
Pathology is central to the diagnosis and treatment of many cancers. During a biopsy, a sample of tissue is collected and examined for abnormal cells. The resulting pathology report can help physicians determine whether cancer is present and, depending on the disease, provide information about its type or grade.
That makes accurate specimen identification essential. If tissue is incorrectly associated with the wrong patient, a pathology result could potentially be placed in the wrong medical record and influence treatment decisions for someone who does not actually have the disease described by the report.
In Barksdale's case, the lawsuit alleges that a specimen showing high-grade endometrial cancer was attributed to her. It further alleges that DNA testing eventually indicated that the cancerous tissue belonged to a different patient.
Taking the Wrong Path For Treatment
According to the lawsuit, Barksdale's diagnosis led to extensive surgery. PEOPLE reported that the lawsuit says the procedure removed her uterus, cervix, ovaries, fallopian tubes, and four lymph nodes. The lawsuit also says that examination of the removed tissue found no malignancy.
A hysterectomy is a major surgical procedure involving removal of the uterus. Depending on the type of operation, the cervix, fallopian tubes and ovaries may also be removed. Cleveland Clinic notes that removing the ovaries before natural menopause can cause menopause to begin immediately, while MedlinePlus lists potential surgical complications including bleeding, infection, blood clots and injury to nearby organs.
These consequences help illustrate why an accurate diagnosis is so important before a patient undergoes an irreversible procedure.
How Biopsy Samples Are Identified and Analyzed
After tissue is collected, it is typically placed in a container labeled with information connecting the specimen to the correct patient and the location from which the tissue was obtained. The specimen is then received by a pathology laboratory, assigned identification information, and processed so that tissue sections can be examined by a pathologist.
Mistakes can potentially occur at several points, including specimen collection, labeling, transportation, laboratory accessioning, or matching a specimen with the corresponding medical order.
Healthcare organizations use multiple safeguards to reduce these risks. Patient identifiers are checked when specimens are collected, while laboratories may use accession numbers, barcode systems and other verification procedures to connect tissue samples with the correct medical record. AP reported that laboratories have adopted barcode-based specimen labeling and other technologies to help reduce identification errors. (AP News)
Using more than one patient identifier is another important safeguard. Identifiers can include a patient's name together with information such as a date of birth or medical-record number. These checks are intended to ensure that the specimen being analyzed belongs to the person whose treatment decisions will be based on the result.
The importance of these safeguards extends beyond pathology. A specimen-identification mistake can potentially lead to unnecessary testing, delays in diagnosis, or treatment being provided to the wrong patient.
However, the existence of these safeguards does not mean that such mistakes are common. AP reported that it is unclear how frequently pathology specimens are mislabeled or mixed up.
A Cry For More Thorough Diagnoses
Barksdale's case demonstrates why accuracy matters at every stage of medical care. A pathology report can influence decisions involving surgery, medication, radiation or other cancer treatments. Before those decisions are made, the underlying specimen must belong to the correct patient.
At the same time, the lawsuit is still pending, and the allegations have not been established by a court. Information about the other patient involved in the alleged mix-up has also not been publicly disclosed because of patient privacy protections.
The case ultimately underscores a fundamental principle of patient safety: the right test result must be connected to the right patient before it is used to make decisions about treatment. For Barksdale, the lawsuit alleges that a failure in that process had consequences that extended from a pathology report to an irreversible surgical procedure.
